Table 3.
AE profiles between treatment groups.
| Placebo (n = 47) |
Chamomile (n = 46) |
P valuea | |
|---|---|---|---|
| Subjects experiencing an AE, n (%) | 9 (19) | 8 (17) | 0.22 |
| AEs | |||
| Bruising | 2 | 0 | |
| Congestion | 1 | 1 | |
| Decreased platelet count | 2 | 0 | |
| Diarrhea | 0 | 1 | |
| Dizziness | 0 | 1 | |
| Drowsiness | 0 | 1 | |
| Dry mouth | 0 | 2 | |
| Fatigue | 0 | 1 | |
| Flushing | 0 | 1 | |
| Herbal taste | 0 | 1 | |
| Nausea | 0 | 3 | |
| Rash/Itchy skin | 1 | 0 | |
| Ringing in ears | 1 | 0 | |
| Sleep paralysis | 1 | 0 | |
| Taste perversion | 2 | 1 | |
| Urinary frequency | 0 | 1 | |
| Vivid dream | 1 | 0 | |
| Wobbly leg | 0 | 1 |
AE: adverse event. Some patients experienced >1 AE.
a
P value was calculated using a chi-square test.